Secondary inhibition of 2-ketoglutarate dehydrogenase complex by MPTP

Neuroreport. 1998 Aug 24;9(12):2781-3. doi: 10.1097/00001756-199808240-00018.

Abstract

The parkinsonism-inducing neurotoxin 1-methyl-4-phenylpyridine (MPP+) acts through inhibition of complex I of the electron transport chain. Recent evidence suggests that it may also act through inhibition of 2-ketoglutarate dehydrogenase complex (KDHC). We confirmed this observation in isolated rat liver mitochondria but found that this inhibition is prevented by preincubation with the radical quencher, cysteine (Cys). KDHC is also inhibited by the NO generator S-nitroso-N-acetyl-penicillamine (SNAP) and this inhibition is similarly blocked by cysteine. MPP+ may inhibit KDHC secondary through a radical-mediated event rather than through direct interaction with KDHC.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine / pharmacology*
  • Animals
  • Dopamine Agents / pharmacology*
  • Enzyme Inhibitors / pharmacology*
  • In Vitro Techniques
  • Ketoglutarate Dehydrogenase Complex / antagonists & inhibitors*
  • Male
  • Mitochondria, Liver / drug effects
  • Penicillamine / analogs & derivatives
  • Penicillamine / pharmacology
  • Rats
  • Rats, Sprague-Dawley
  • Reactive Oxygen Species / physiology
  • S-Nitroso-N-Acetylpenicillamine
  • Sodium-Potassium-Exchanging ATPase / antagonists & inhibitors
  • Spectrophotometry, Ultraviolet

Substances

  • Dopamine Agents
  • Enzyme Inhibitors
  • Reactive Oxygen Species
  • S-Nitroso-N-Acetylpenicillamine
  • 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
  • Ketoglutarate Dehydrogenase Complex
  • Sodium-Potassium-Exchanging ATPase
  • Penicillamine